UCLA Team Secures $2.1 Million Grant for Diabetes Research Using AI
April 19, 2025 - 09:01
A team from the UCLA Fielding School of Public Health has been awarded a substantial grant of $2.1 million from the National Institutes of Health (NIH) to advance research in diabetes management. This funding will focus on harnessing the power of artificial intelligence to enhance risk assessment for individuals affected by diabetes and its associated complications.
The innovative project aims to develop sophisticated AI algorithms that can analyze vast amounts of health data, enabling more accurate predictions of diabetes-related risks. By improving risk assessment, the research hopes to facilitate early intervention strategies, ultimately leading to better health outcomes for patients.
The team is optimistic that their work will not only contribute to a deeper understanding of diabetes but also pave the way for personalized treatment plans. With diabetes affecting millions worldwide, this research could significantly impact public health initiatives and improve the quality of life for those living with the condition.
MORE NEWS
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...